Status: current, Defined. Date: 30-Nov 2019. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4270801000168114 | Kanjinti (trastuzumab 150 mg) powder for injection, 150 mg vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
4270811000168112 | Kanjinti 150 mg powder for injection, 150 mg vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Kanjinti 150 mg powder for injection, 150 mg vial | Is a | Kanjinti | true | Inferred relationship | Some | ||
Kanjinti 150 mg powder for injection, 150 mg vial | Is a | trastuzumab 150 mg injection, vial | true | Inferred relationship | Some | ||
Kanjinti 150 mg powder for injection, 150 mg vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
Kanjinti 150 mg powder for injection, 150 mg vial | has manufactured dose form | powder for injection | true | Inferred relationship | Some | ||
Kanjinti 150 mg powder for injection, 150 mg vial | has unit of use | vial | true | Inferred relationship | Some | 1405442033 | |
Kanjinti 150 mg powder for injection, 150 mg vial | has intended active ingredient | trastuzumab | true | Inferred relationship | Some | 1739644544 | |
Kanjinti 150 mg powder for injection, 150 mg vial | has Australian BoSS | trastuzumab | true | Inferred relationship | Some | 1739644544 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Kanjinti 150 mg powder for injection, 1 vial | has TPUU | True | Kanjinti 150 mg powder for injection, 150 mg vial | Inferred relationship | Some | 687194447 |
Kanjinti 150 mg powder for injection, 1 vial | has TPUU | True | Kanjinti 150 mg powder for injection, 150 mg vial | Inferred relationship | Some | 1892751727 |
Reference Sets
Trade product unit of use reference set